Stay updated on Ramucirumab vs Placebo in HCC Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab vs Placebo in HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The screenshots show the same ClinicalTrials.gov study details page for NCT02435433 with no additions or deletions to core content; only minor visual/layout differences are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:15:22.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Added a government funding notice and a new software version (v3.2.0); removed the previous version reference (v3.1.0).
    Difference
    1.0%
    Check dated 2025-10-05T09:56:02.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Upgraded to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); indicates content pruning alongside a version update.
    Difference
    0.1%
    Check dated 2025-09-28T03:12:00.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 (replacing v3.0.1); the Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:36:32.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T15:11:31.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and various locations, particularly in South Korea and Taiwan, while also removing outdated location terms and references. Additionally, new MedlinePlus related topics on drug safety and liver cancer have been introduced.
    Difference
    3%
    Check dated 2025-08-30T11:52:11.000Z thumbnail image

Stay in the know with updates to Ramucirumab vs Placebo in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.